IBM Partners With Tekes, Expands Watson Health To Finland
Zacks Investment Research | Sep 14, 2016 10:59PM ET
International Business Machines Corp (NYSE:IBM) recently announced a partnership with Tekes, a Finland-based funding agency. The partnership will enable Finland to make use of cognitive computing technology offered by Watson Health.
Watson Health will help doctors to provide better treatment in the country as well as boost the business ecosystem and innovation related to healthcare in the country.
Advantage Finland
We note that the collaboration will help Finland in many ways. Some of the probable outcomes of the partnership are opening of start-ups, improved opportunities for Finland based companies to grow globally and digitalization of the healthcare sector, which will benefit both small and large companies associated with the field.
Per the deal, Finnish doctors and researchers will collaborate with Watson Health researchers, engineers, data scientists and designers to develop innovative healthcare solutions and applications. This will lead to advancement of research and development and innovation in the country.
IBM is planning to set up a Watson Health Center of Excellence in the country along with a Nordic Healthcare Competence Center and a National Imaging Center of Excellence, both of which will be the first of their kind outside the U.S. IBM intends to employ 150 people in these healthcare centers in the near future.
Finland’s University of Jyvaskyla has been collaborating with IBM Watson for sometime now and the results have been encouraging. Moreover, the focus on digitalization as well as digital services is helping the university to innovate using IBM’s technology.
Our Take
With cognitive computing gradually gaining traction in the healthcare segment with its capability to diagnose diseases accurately, IBM’s Watson Health has huge growth opportunity in healthcare applications. We believe IBM will continue to pursue similar kind of collaborations that will help in expanding its global presence in the long haul.
INTL BUS MACH Price
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.